Create assured and robust market forecasts
IMS Therapy Forecaster combines rigorous assessment of historical data with the identification and evaluation of key future issues.
BASELINE QUANTITATIVE PROJECTION
The initial baseline projections are produced through IMS’s proven forecast model with the most recent IMS Health market information and analytics:
10 years of historical data
-
Sales
-
Volume and Price
-
Medical data
IDENTIFY, EVALUATE & QUANTIFY EVENTS
All forecasts are based on extensive primary and secondary research from all key stakeholders in the industry, to take account of unprecedented events that cannot be captured by the initial baseline projection:
Market Events
-
Macroeconomic factors, Regulatory, Legislation, FDA warnings, Clinical trial results, Changes in prescribers’ behavior, Demographics and Inflation
New Product Launches
-
Including line extensions and New categories
Product Lifecycle
-
Including new indications, Patent extensions and expiries, and OTC switches
THE FORECAST – “EVENTED” FORECAST
IMS Therapy Forecaster presents 10-year forecasts, including:
-
Sales forecasts
-
Volume forecasts
Forecasts cover an average of 40+ATCs for each of the 10 countries covered:
France, Germany, Italy, Spain, UK, USA, Canada, Japan, China & Mexico
